Clinical Trial: A Study to Learn About Three Forms of The Study Medicine (Ritlecitinib) in Healthy Adults
Study Status: COMPLETED
Recruit Status: COMPLETED
Condition: Healthy Volunteers
Study Type: INTERVENTIONAL
Official Title: A PHASE 1, OPEN-LABEL STUDY IN HEALTHY PARTICIPANTS TO INVESTIGATE THE PHARMACOKINETICS OF RITLECITINIB FOLLOWING SINGLE ORAL ADMINISTRATION OF MODIFIED RELEASE FORMULATIONS UNDER FED AND FASTED CONDI
Brief Summary:
The purpose of this study is to compare if three forms of study medicine (called ritlecitinib) get processed differently in healthy adults.This study is seeking healthy participants who have:Aged 18 years or older;male or female who are healthy as determined by medical assessment;BMI of 16-32 kg/m2, and a total body weight >45 kg (99 lb).All participants in this study will receive a ritlecitinib oral dose in three different forms (solution, capsule 1 and capsule 2).The study will take up to 2.5 months,…
Read more